WEDNESDAY 13 JULY 2011
10:30 – 12:00
Symposium 12 - Current Topics on Human Papillomavirus
Co-chairs:
Max Chernesky, McMaster University, Hamilton, Canada
François Coutlée, Université de Montréal, Montréal, Canada
Synopsis
Enormous advances have been made in our understanding of HPV and in the development of HPV care and prevention methods. However, a significant barrier that we now face in realizing the full benefits of these advances is the lack of awareness and the persistence of inaccurate information. The aim of this symposium is to provide health professionals with a current, balanced, clinically relevant and evidence-based summary of the essential HPV knowledge that is required to provide proper care, treatment, and counseling as well as apply efficiently preventive measures.
Presentations
Transmission of Human Papillomavirus Infections
Burchell AN1, Coutlée F, Tellier P, Hanley J, Franco EL;
(1) Department of Oncology, Faculty of Medicine, McGill University (Montreal, Canada);
Screening for cervical cancer in the era of HPV vaccination
Eduardo L. Franco , McGill University (Montreal, Canada)
What is the latest data from the 2 commercially available prophylactic cervical cancer vaccines?
Suzanne Garland, Royal Women's hospital (Victoria, Australia)
Genital warts: prevention, diagnosis, treatment and counseling
Marc Steben, Institut national de santé publique du Québec (Montréal, Canada)
10:30 – 12:00
Symposium 13 - Respondent Driven Sampling: where we are and where should we be going?
Co-Chairs:
Richard White, London School of Hygiene and Tropical Medicine, London, UK
David Wilson, World Bank Group, Washington DC, USA
Synopsis
RDS is a variant of snowball sampling that is primarily used to estimate the characteristics of hard-to-reach groups, such as the HIV prevalence of drug users. RDS has quickly become popular, because of rapid recruitment and the potential of unbiased estimation. However, RDS is not without its critics. If estimates are biased or variance high, RDS will be less useful. This symposium asks what should RDS be used for? It reports on two robust evaluations of RDS and its most high-profile application - monitoring HIV behaviours among IDUs in the US by CDC. It will end with a discussion including the hot topics for RDS research.
Presentations
Respondent Driven Sampling: Uses, Assumptions, Limits and Prospects
Simon Frost, University of Cambridge (Cambridge, UK)
Assessing Respondent-Driven Sampling
Sharad GOEL, Yahoo Research (New-York, USA)
An empirical evaluation of Respondent-Driven Sampling
White, RG1, Frost, S, McCreesh, N, Seeley, J, Katongole, J, Ndagire Tarsh, M, Ndungutse, R, Jichi, F, Maher, D, Sonnenberg, P, Copas, A, Hayes, RJ,;
(1) London School of Hygiene and Tropical Medicine, London, UK;
Use of respondent-driven sampling for monitoring HIV behaviors among injecting drug users in the United States
Amy Lansky1, Elizabeth A. DiNenno, Cyprian Wejnert;
(1) Centre for Disease Control and Prevention (Atlanta, USA)
10:30 – 12:00
Late Breaker Symposium - Questioning Azithromycin for Uncomplicated Genital Chlamydial Infection
Co-chairs:
H. Hunter Handsfield, MD, University of Washington Center for AIDS and STD and Battelle Centers for Public Health Research and Evaluation, Seattle, Washington, USA
Dr. Janet Wilson MB ChB, FRCP, Centre for Sexual Health, The General Infirmary at Leeds, Leeds, UK
Synopsis
The results of recent studies question the efficacy of single-dose azithromycin for uncomplicated genital chlamydial infection. The available data, controversies, possible interim treatment recommendations, and potential research agendas will be addressed, with ample opportunity for audience participation.
Presentations
Biological and Molecular Aspects of Chlamydia trachomatis Antimicrobial Resistance and Persistence
Patrick Horner, University of Bristol and University Hospitals Bristol NHS Foundation Trust (Bristol, UK)
Efficacy of Azithromycin for Uncomplicated Chlamydial Infection: Early Studies and New Doubts
H. Hunter Handsfield, University of Washington Center for AIDS and STD (Seattle, USA)
Chlamydia trachomatis Treatment Efficacy: Review of Treatment Studies in the Nucleic Acid Amplification Era
William M. Geisler, University of Alabama at Birmingham (Birmingham, USA)
Panel Discussion (with audience participation): Research Agenda and Interim Recommendations: Where Do We Go from Here?
Panelists
Dr. Horner
Dr. Handsfield
Dr. Geisler
Kimberly Workowski, MD [TBC], Division of STD Prevention, National Center for HIV/AIDS, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
13:30 – 15:00
Symposium 14 - Research in Progress: Updates from American STD Association Developmental Award Recipients
Co-chairs:
Jeanne Marrazzo, University of Washington, Seattle, USA
Kees Rietmeijer, University of Colorado, Denver, USA
Synopsis
This symposium will highlight contributions from recipients of Career Development Awards from the American Sexually Transmitted Disease Association (ASTDA). The ASTDA started funding promising young investigators with these 2-year awards through a competitive process in 2008. In this session, recipients from the program's first 3 years of funding will discuss preliminary findings from their work. This session is intended to highlight the value of and need for promoting the entry of junior researchers into the field STD field.
Presentations
Genital and Oral Human Papillomavirus in Adolescent Males
Bree A. Weaver1, Darron Brown, J.Dennis Fortenberry;
(1) Indiana University School of Medicine (Indianapolis, USA)
A study of African American and Latina Women and Human Papillomavirus: Lessons Learned
Loida Bonney1, Michael Fost, Yun F. Wang, Victoria L. Green, Gina Wingood, Carlos del Rio, Richard Rothenberg;
(1) Emory University School of Medicine;
Evaluating the Internet as an STD Risk Environment for Teens: Findings from the Communication, Health, and Teens (CH@T) Study
Buhi ER1, Klinkenberger N, Blunt H, Daley EM, Baldwin J, Rietmeijer C;
(1) University of South Florida, College of Public Health (Tampa, USA);
Detecting Chlamydial and Gonococcal Infections through Social and Sexual Networks
AA Al-Tayyib1, CA Rietmeijer;
(1) Denver Public Health (Denver, USA);
Treponema pallidum Sigma24 Regulon and Envelope Stress Response
Lorenzo Giacani1, Oleg Denisenko, Martin Tompa, Barbara Molini, Arturo Centurion-Lara;
(1) University of Washington (Seattle, USA)
Prevalence and predictors of Trichomonas Infection in Incarcerated Women
Ank Nijhawan1, Rachel Salloway, Sarah Andrea, Jesse Champion, Michaela Seadale, Kimberle Chapin, Jennifer G Clarke;
(1) Harvard Medical School (Boston, USA);
13:30 – 15:00
Symposium 15 - STI epidemiology in Europe: challenges for prevention and control
Co-chairs:
Marita Van De Laar, European Centre for Disease Prevention and Control, Stockholm, Sweden
Catherine Ison, Health Protection Agency, London, UK
Synopsis
The symposium covers the coordination of European-wide STI and HIV surveillance and an update of the specific LGV situation in MSM. Results from the first MSM internet survey to collect information on current sexual practices, attitudes & beliefs and access to testing and care will be presented. This symposium will bring together the leaders from several EU-funded programmes with special focus on MSM.
The objectives are to present:
1. European STI and HIV expert networks; implementation of enhanced surveillance for these diseases in Europe; surveillance activities covering 20 years of STI and 2 years of gonococcal AMR surveillance;
2. First results from the European MSM Internet Survey with respect to access to STI testing;
3. An update on the on-going LGV epidemic in European countries, the public health response and the key factors that affect transmission.
Presentations
Sexually Transmitted Infections in Europe – coordinating the European STI network
Marita van de Laar, European Centre for Disease Prevention and Control (Stockholm, Sweden)
European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP): Towards Timelier Monitoring
M. J. Cole1, S. A. Chisholm, M. Unemo, S. Hoffmann, M. J. W. van de Laar, C. A. Ison ;
(1) Health Protection Agency (London, United Kingdom);
European MSM Internet Survey (EMIS) - Differences in STI testing in European countries
Ulrich Marcus1, Axel J. Schmidt, Michele Breveglieri, Percy Fernandes Davila, Laia Ferrer, Cinta Folch, Ford Hickson, Harm J. Hospers, Massimo Mirandola, David Reid, Peter Weatherburn, for the EMIS network;
(1) Robert Koch Institute, Department for Infectious Disease Epidemiology (Berlin, Germany);
Re-emergence of Lymphogranuloma venereum in Europe and the public health response
Helen Ward1, Henry J.C. de Vries, Marita van de Laar;
(1) Imperial College (London, United Kingdom);